Your session is about to expire
← Back to Search
Lumason for Vesicoureteral Reflux
Study Summary
This trial is studying a safe, radiation-free ultrasound technique that may improve the ability to diagnose or evaluate kidney scarring.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a major birth defect in my kidney's structure.I am between 6 months and 35 years old and scheduled for a renal function scan at BCH.I do not have severe heart or lung diseases.
- Group 1: Contrast Enhanced Ultrasound
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age limit for participants in this trial over 60?
"Participants must be between 6 months and 35 years of age in order to join this medical study."
Are there any vacancies available in the trial for prospective participants?
"Unfortunately, this clinical trial has concluded its recruitment phase. It was initially posted on August 22nd 2019 and underwent its last update on the 3rd of August 2021. Alternatively, there are currently three trials enrolling patients with vesico-ureteral reflux and 14 studies leveraging Lumason looking for participants to join in their research initiatives."
What is the current number of individuals taking part in this research study?
"Unfortunately, this clinical trial is not accepting recruits at the moment. It was first posted on August 22nd 2019 and its most recent update occurred on August 3rd 2021. If you are interested in other trials, there are currently 3 studies involving vesico-ureteral reflux that require volunteers along with 14 research initiatives related to Lumason treatments."
What potential risks should one be aware of when considering Lumason?
"The safety of Lumason was appraised as a 1, indicating that it is in its early stages and only has limited data to support its efficacy."
Is this experiment a pioneering endeavor?
"Lumason has been under investigation since 2017, when the first trial was conducted by Bracco Diagnostics Inc. After a successful Phase < 1 approval in 2018, there are now 14 active studies running across 10 metropolises and 3 nations."
Are there any other empirical investigations involving Lumason?
"Currently, 14 different clinical trials are in progress for Lumason. Of those experiments, two are at Phase 3 and 18 research sites can be found throughout Philadelphia, Pennsylvania."
Is there an opportunity to take part in this experiment?
"This medical trial is currently seeking 70 patients with vesico-ureteral reflux aged between 6 months and 35 years. To be eligible, the participant must meet certain requirements: they must have been scheduled for a Boston Children's Hospital (BCH) DMSA scan to assess renal function or scarring and also fit within the age range of 6 month olds up to 35 year olds."
Share this study with friends
Copy Link
Messenger